BML Inc operates in the Medical laboratories sector.
In addition to historical fundamental analyses, the complete report available to purchase compares BML Inc with three other
pharmaceutical manufacturers in Asia:
Medical & Biological Laboratories Company Limited
sales of 7.61 billion Japanese Yen [US$61.57 million]
Falco Holdings Co Ltd
(46.59 billion Japanese Yen [US$376.94 million]
Miraca Holdings Incorporated
(204.67 billion Japanese Yen [US$1.66 billion]
of which 65%
was Clinical Examination).
BML Inc reported sales of ¥104.40 billion (US$844.63 million)
March of 2015.
increase of 5.4%
versus 2014, when the company's sales were ¥99.05 billion.
Sales at BML Inc have increased during each of the previous five years
(and since 2010, sales have increased a total of 32%).